ArticleImmunoHorizons2025
Sex differences in donor T cell targeting of host splenocyte subpopulations in acute and chronic murine graft-vs-host disease: results from a novel induction and assessment protocol with implications for lupus-like autoimmunity.
Article in ImmunoHorizons, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Absolute risk trade-offs of donor age, sex, and graft source in PTCy-based transplantation.Blood advances · 2026Article
Corrections and comments
- Update of
Authors and funding
2 authors.
Funding
Abstract
Using the parent-into-F1 mouse model, we compared in vivo sex differences in acute graft-vs-host (GVHD) disease, a Th1- response and in chronic GVHD, a T follicular helper cell (Tfh) lupus-like antibody response. Using a novel induction protocol standardized for donor CD8 content, we analyzed both a sub-threshold and a supra-threshold dose for twenty flow cytometry outcome variables encompassing splenic subsets and T cell activation markers. A large majority (≥16) of the outcome variables identified significant differences in the two phenotypes, many with very large effect sizes. In acute GVHD, B cells exhibited the greatest degree of depletion in both sexes; however, the male response was significantly stronger. Sex differences in chronic GVHD were more widespread; females exhibited significantly greater numbers of total splenocytes and host CD4 T cells, Tfh cells, B cells and CD8 T cells consistent with greater female autoantibody production in this model. The more potent male CTL response in acute GVHD conflicts with reports of greater female CTL responses following infections or vaccines possibly reflecting the absence of exogenous innate immune stimuli in the GVHD model. To our knowledge, this study is the first to compare sex differences in splenic cellular composition and T cell activation for acute and chronic GVHD mice at 2 wk post-induction using 2 different doses of donor splenocytes standardized to CD8 T cell numbers and using an expanded number of outcome variables. The implications for lupus pathogenesis are discussed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.